Battle of the hemichannels - Connexins and Pannexins in ischemic brain injury

International Journal of Developmental Neuroscience

Volumn 45, Issue , 2015, Pages 66-74

  Davidson, J O ^a   Green, C R ^a   Bennet, L ^a   Gunn, A J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cerebral ischemia; Connexin 43; Fetal sheep; Hemichannel; Neuroprotection; Pannexin

Indexed keywords

ACT 1; ADENOSINE TRIPHOSPHATE; ANTICONVULSIVE AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BRAIN PROTEIN; CALCIUM ION; CARBENOXOLONE; CONNEXIN 30; CONNEXIN 43; FLUFENAMIC ACID; GADOLINIUM; GAP JUNCTION PROTEIN; GAP JUNCTION PROTEIN 19; GAP JUNCTION PROTEIN 26; GAP JUNCTION PROTEIN 27; GLUTAMIC ACID; GLYCYRRHETINIC ACID; NEUROPROTECTIVE AGENT; NEUROTROPHIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; OCTANOL; PANNEXIN; PANNEXIN 1; PANNEXIN 2; PEPTIDE 5; PROBENECID; QUININE; UNCLASSIFIED DRUG; NERVE PROTEIN;

ARTICLE; ASTROCYTE; ASTROCYTIC SYNCYTIUM; BLOOD BRAIN BARRIER; BRAIN INFARCTION; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CAPILLARY DYSFUNCTION; CELL DEATH; CELL FUNCTION; CELL INTERACTION; CELL MEMBRANE; CELL MIGRATION; CELL SWELLING; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM DISEASE; DIABETIC FOOT; DRUG ACTIVITY; DRUG APPROVAL; EYE BURN; GAP JUNCTION; HUMAN; LEG ULCER; MICROGLIA; NEUROPROTECTION; NONHUMAN; PARACRINE SIGNALING; PATHOPHYSIOLOGY; PERINATAL ISCHEMIC BRAIN INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SEIZURE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SYNCYTIUM; TRANSLATIONAL RESEARCH; UNSPECIFIED SIDE EFFECT; VASCULAR DISEASE; WOUND HEALING; ANIMAL; BIOLOGICAL MODEL; BRAIN INJURY; METABOLISM; PATHOLOGY;

ANIMALS; BRAIN INJURIES; BRAIN ISCHEMIA; CONNEXINS; GAP JUNCTIONS; HUMANS; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS;

EID: 84941179189     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2014.12.007     Document Type: Article

References (132)

1. Fernandez-Lopez D., Natarajan N., Ashwal S., Vexler Z.S. Mechanisms of perinatal arterial ischemic stroke. J. Cereb. Blood Flow Metab. 2014, 34(6):921-932.
2. Wassink G., Gunn E.R., Drury P.P., Bennet L., Gunn A.J. The mechanisms and treatment of asphyxial encephalopathy. Front Neurosci. 2014, 8:40.
3. Benders M.J., Groenendaal F., Uiterwaal C.S., de Vries L.S. Perinatal arterial stroke in the preterm infant. Semin. Perinatol. 2008, 32(5):344-349.
4. Golomb M.R., Garg B.P., Edwards-Brown M., Williams L.S. Very early arterial ischemic stroke in premature infants. Pediatr. Neurol. 2008, 38(5):329-334.
5. Vannucci R.C. Hypoxic-ischemic encephalopathy. Am. J. Perinatol. 2000, 17(3):113-120.
6. Edwards A.D., Brocklehurst P., Gunn A.J., Halliday H., Juszczak E., Levene M., et al. Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010, 340:c363.
7. Committee on Understanding Premature Birth and Assuring Healthy Outcomes Preterm Birth: Causes, Consequences, and Prevention 2007, Institute of Medicine of the National, Washington DC, USA. R.E. Behrman, A.S. Butler (Eds.).
8. Thornton J.S., Ordidge R.J., Penrice J., Cady E.B., Amess P.N., Punwani S., et al. Temporal and anatomical variations of brain water apparent diffusion coefficient in perinatal cerebral hypoxic-ischemic injury: relationships to cerebral energy metabolism. Magn. Reson. Med. 1998, 39(6):920-927.
9. Williams C.E., Gunn A., Gluckman P.D. Time course of intracellular edema and epileptiform activity following prenatal cerebral ischemia in sheep. Stroke 1991, 22(4):516-521.
10. Williams C.E., Gunn A.J., Mallard C., Gluckman P.D. Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study. Ann. Neurol. 1992, 31(1):14-21.
11. Gunn A.J., Gunn T.R., de Haan H.H., Williams C.E., Gluckman P.D. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J. Clin. Invest. 1997, 99(2):248-256.
12. Rawanduzy A., Hansen A., Hansen T.W., Nedergaard M. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J. Neurosurg. 1997, 87(6):916-920.
13. de Pina-Benabou M.H., Szostak V., Kyrozis A., Rempe D., Uziel D., Urban-Maldonado M., et al. Blockade of gap junctions in vivo provides neuroprotection after perinatal global ischemia. Stroke 2005, 36(10):2232-2237.
14. Fonseca C.G., Green C.R., Nicholson L.F. Upregulation in astrocytic Connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res. 2002, 929(1):105-116.
15. Nakase T., Yoshida Y., Nagata K. Enhanced Connexin 43 immunoreactivity in penumbral areas in the human brain following ischemia. Glia 2006, 54(5):369-375.
16. Cronin M., Anderson P.N., Cook J.E., Green C.R., Becker D.L. Blocking Connexin 43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol. Cell. Neurosci. 2008, 39(2):152-160.
17. Danesh-Meyer H.V., Huang R., Nicholson L.F., Green C.R. Connexin 43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemia. J. Clin. Neurosci. 2008, 15:1253-1263.
18. Xie M., Yi C., Luo X., Xu S., Yu Z., Tang Y., et al. Glial gap junctional communication involvement in hippocampal damage after middle cerebral artery occlusion. Ann. Neurol. 2011, 70(1):121-132.
19. Tamura K., Alessandri B., Heimann A., Kempski O. The effect of a gap-junction blocker, carbenoxolone, on ischemic brain injury and cortical spreading depression. Neuroscience 2011, 194:262-271.
20. Belousov A.B., Wang Y., Song J.H., Denisova J.V., Berman N.E., Fontes J.D. Neuronal gap junctions play a role in the secondary neuronal death following controlled cortical impact. Neurosci. Lett. 2012, 524(1):16-19.
21. Nakase T., Fushiki S., Naus C.C. Astrocytic gap junctions composed of Connexin 43 reduce apoptotic neuronal damage in cerebral ischemia. Stroke 2003, 34(8):1987-1993.
22. Nakase T., Sohl G., Theis M., Willecke K., Naus C.C. Increased apoptosis and inflammation after focal brain ischemia in mice lacking Connexin 43 in astrocytes. Am. J. Pathol. 2004, 164(6):2067-2075.
23. O'Carroll S.J., Alkadhi M., Nicholson L.F., Green C.R. Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. Cell Commun. Adhes. 2008, 15(1):27-42.
24. Davidson J.O., Green C.R., Nicholson L.F., Bennet L., Gunn A.J. Deleterious effects of high dose Connexin 43 mimetic peptide infusion after cerebral ischaemia in near-term fetal sheep. Int. J. Mol. Sci. 2012, 13(5):6303-6319.
25. Davidson J.O., Drury P.P., Green C.R., Nicholson L.F., Bennet L., Gunn A.J. Connexin hemichannel blockade is neuroprotective after asphyxia in preterm fetal sheep. PLoS One 2014, 9(5):e96558.
26. Davidson J.O., Green C.R., Nicholson L.F., Bennet L., Gunn A.J. Connexin hemichannel blockade is neuroprotective after, but not during, global cerebral ischemia in near-term fetal sheep. Exp. Neurol. 2013, 248:301-308.
27. Davidson J.O., Green C.R., Nicholson L.F., O'Carroll S.J., Fraser M., Bennet L., et al. Connexin hemichannel blockade improves outcomes in a model of fetal ischemia. Ann. Neurol. 2012, 71(1):121-132.
28. Orellana J.A., Hernandez D.E., Ezan P., Velarde V., Bennett M.V., Giaume C., et al. Hypoxia in high glucose followed by reoxygenation in normal glucose reduces the viability of cortical astrocytes through increased permeability of Connexin 43 hemichannels. Glia 2010, 58(3):329-343.
29. Danesh-Meyer H.V., Kerr N.M., Zhang J., Eady E.K., O'Carroll S.J., Nicholson L.F., et al. Connexin 43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 2012, 135(2):506-520.
30. O'Carroll S.J., Gorrie C.A., Velamoor S., Green C.R., Nicholson L.F. Connexin 43 mimetic peptide is neuroprotective and improves function following spinal cord injury. Neurosci. Res. 2013, 75(3):256-267.
31. Madry C., Haglerod C., Attwell D. The role of Pannexin hemichannels in the anoxic depolarization of hippocampal pyramidal cells. Brain 2010, 133(Pt 12):3755-3763.
32. Orellana J.A., Froger N., Ezan P., Jiang J.X., Bennett M.V., Naus C.C., et al. ATP and glutamate released via astroglial Connexin 43 hemichannels mediate neuronal death through activation of Pannexin 1 hemichannels. J. Neurochem. 2011, 118(5):826-840.
33. Kumar N.M., Gilula N.B. The gap junction communication channel. Cell 1996, 84(3):381-388.
34. Sohl G., Maxeiner S., Willecke K. Expression and functions of neuronal gap junctions. Nat. Rev. Neurosci. 2005, 6(3):191-200.
35. Willecke K., Eiberger J., Degen J., Eckardt D., Romualdi A., Guldenagel M., et al. Structural and functional diversity of Connexin genes in the mouse and human genome. Biol. Chem. 2002, 383(5):725-737.
36. Rash J.E., Yasumura T., Dudek F.E., Nagy J.I. Cell-specific expression of Connexins and evidence of restricted gap junctional coupling between glial cells and between neurons. J. Neurosci. 2001, 21(6):1983-2000.
37. Chew S.S., Johnson C.S., Green C.R., Danesh-Meyer H.V. Role of Connexin 43 in central nervous system injury. Exp. Neurol. 2010, 225(2):250-261.
38. Pepper M.S., Montesano R., el Aoumari A., Gros D., Orci L., Meda P. Coupling and Connexin 43 expression in microvascular and large vessel endothelial cells. Am. J. Physiol. 1992, 262(5 Pt 1):C1246-C1257.
39. Eugenin E.A., Eckardt D., Theis M., Willecke K., Bennett M.V., Saez J.C. Microglia at brain stab wounds express Connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha. Proc. Natl. Acad. Sci. U. S. A. 2001, 98(7):4190-4195.
40. Stout C.E., Costantin J.L., Naus C.C., Charles A.C. Intercellular calcium signaling in astrocytes via ATP release through Connexin hemichannels. J. Biol. Chem. 2002, 277(12):10482-10488.
41. Kang J., Kang N., Lovatt D., Torres A., Zhao Z., Lin J., et al. Connexin 43 hemichannels are permeable to ATP. J. Neurosci. 2008, 28(18):4702-4711.
42. Bruzzone S., Franco L., Guida L., Zocchi E., Contini P., Bisso A., et al. A self-restricted CD38-Connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J. Biol. Chem. 2001, 276(51):48300-48308.
43. Bruzzone S., Guida L., Zocchi E., Franco L., De Flora A. Connexin 43 hemi channels mediate Ca2+-regulated transmembrane NAD+ fluxes in intact cells. FASEB 2001, 15(1):10-12.
44. Moore A.R., Zhou W.L., Sirois C.L., Belinsky G.S., Zecevic N., Antic S.D. Connexin hemichannels contribute to spontaneous electrical activity in the human fetal cortex. Proc. Natl. Acad. Sci. U. S. A. 2014, 111(37):E3919-E3928.
45. Panchin Y., Kelmanson I., Matz M., Lukyanov K., Usman N., Lukyanov S. A ubiquitous family of putative gap junction molecules. Curr. Biol. 2000, 10(13):R473-474.
46. Yen M.R., Saier M.H. Gap junctional proteins of animals: the innexin/Pannexin superfamily. Prog. Biophys. Mol. Biol. 2007, 94(1-2):5-14.
47. Bruzzone R., Barbe M.T., Jakob N.J., Monyer H. Pharmacological properties of homomeric and heteromeric Pannexin hemichannels expressed in Xenopus oocytes. J. Neurochem. 2005, 92(5):1033-1043.
48. Boassa D., Ambrosi C., Qiu F., Dahl G., Gaietta G., Sosinsky G. Pannexin 1 channels contain a glycosylation site that targets the hexamer to the plasma membrane. J. Biol. Chem. 2007, 282(43):31733-31743.
49. Ishikawa M., Iwamoto T., Nakamura T., Doyle A., Fukumoto S., Yamada Y. Pannexin 3 functions as an ER Ca2+ channel, hemichannel, and gap junction to promote osteoblast differentiation. J. Cell. Biol. 2011, 193(7):1257-1274.
50. Bruzzone R., Hormuzdi S.G., Barbe M.T., Herb A., Monyer H. Pannexins, a family of gap junction proteins expressed in brain. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(23):13644-13649.
51. Ray A., Zoidl G., Weickert S., Wahle P., Dermietzel R. Site-specific and developmental expression of Pannexin 1 in the mouse nervous system. Eur. J. Neurosci. 2005, 21(12):3277-3290.
52. Vogt A., Hormuzdi S.G., Monyer H. Pannexins 1 and 2 expression in the developing and mature rat brain. Brain Res. Mol. Brain Res. 2005, 141(1):113-120.
53. Iglesias R., Dahl G., Qiu F., Spray D.C., Scemes E. Pannexin 1: the molecular substrate of astrocyte hemichannels. J. Neurosci. 2009, 29(21):7092-7097.
54. Bargiotas P., Krenz A., Hormuzdi S.G., Ridder D.A., Herb A., Barakat W., et al. Pannexins in ischemia-induced neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(51):20772-20777.
55. Paul D.L., Ebihara L., Takemoto L.J., Swenson K.I., Goodenough D.A. Connexin 46, a novel lens gap junction protein, induces voltage-gated currents in nonjunctional plasma membrane of Xenopus oocytes. J. Cell. Biol. 1991, 115(4):1077-1089.
56. Ebihara L., Steiner E. Properties of a nonjunctional current expressed from a rat Connexin 46 cDNA in Xenopus oocytes. J. Gen. Physiol. 1993, 102(1):59-74.
57. Li H., Liu T.F., Lazrak A., Peracchia C., Goldberg G.S., Lampe P.D., et al. Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J. Cell. Biol. 1996, 134(4):1019-1030.
58. Contreras J.E., Sanchez H.A., Eugenin E.A., Speidel D., Theis M., Willecke K., et al. Metabolic inhibition induces opening of unapposed Connexin 43 gap junction hemichannels and reduces gap junctional communication in cortical astrocytes in culture. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(1):495-500.
59. Kondo R.P., Wang S.Y., John S.A., Weiss J.N., Goldhaber J.I. Metabolic inhibition activates a non-selective current through Connexin hemichannels in isolated ventricular myocytes. J. Mol. Cell. Cardiol. 2000, 32(10):1859-1872.
60. Gluckman P.D., Wyatt J.S., Azzopardi D., Ballard R., Edwards A.D., Ferriero D.M., et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005, 365(9460):663-670.
61. Azzopardi D., Brocklehurst P., Edwards D., Halliday H., Levene M., Thoresen M., et al. The TOBY Study: whole body hypothermia for the treatment of perinatal asphyxial encephalopathy: a randomised controlled trial. BMC Pediatr. 2008, 8:17.
62. Shankaran S., Laptook A.R., Ehrenkranz R.A., Tyson J.E., McDonald S.A., Donovan E.F., et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N. Engl. J. Med. 2005, 353(15):1574-1584.
63. Thompson R.J., Zhou N., MacVicar B.A. Ischemia opens neuronal gap junction hemichannels. Science 2006, 312(5775):924-927.
64. Weilinger N.L., Tang P.L., Thompson R.J. Anoxia-induced NMDA receptor activation opens Pannexin channels via Src family kinases. J. Neurosci. 2012, 32(36):12579-12588.
65. R.J. Thompson, Pannexin channels and ischaemia, J. Physiol., 2014, Epub Nov 10.
66. Bargiotas P., Krenz A., Monyer H., Schwaninger M. Functional outcome of Pannexin-deficient mice after cerebral ischemia. Channels 2012, 6(6):453-456.
67. Walker D.W., Pratt N. Effect of probenecid on breathing movements and cerebral clearance of prostaglandin E2 in fetal sheep. J. Physiol. 1998, 506(1):253-262.
68. Stone T.W., Connick J.H. Quinolinic acid and other kynurenines in the central nervous system. Neuroscience 1985, 15(3):597-617.
69. Silverman W., Locovei S., Dahl G. Probenecid, a gout remedy, inhibits Pannexin 1 channels. Am. J. Physiol. Cell. Physiol. 2008, 295(3):C761-767.
70. Xiong X.X., Gu L.J., Shen J., Kang X.H., Zheng Y.Y., Yue S.B., et al. Probenecid protects against transient focal cerebral ischemic injury by inhibiting HMGB1 release and attenuating AQP4 expression in mice. Neurochem. Res. 2014, 39(1):216-224.
71. Bhaskaracharya A., Dao-Ung P., Jalilian I., Spildrejorde M., Skarratt K.K., Fuller S.J., et al. Probenecid blocks human P2X7 receptor-induced dye uptake via a Pannexin-1 independent mechanism. PLoS One 2014, 9(3):e93058.
72. Iwabuchi S., Kawahara K. Functional significance of the negative-feedback regulation of ATP release via Pannexin-1 hemichannels under ischemic stress in astrocytes. Neurochem. Int. 2011, 58(3):376-384.
73. Bennet L., Roelfsema V., George S., Dean J.M., Emerald B.S., Gunn A.J. The effect of cerebral hypothermia on white and grey matter injury induced by severe hypoxia in preterm fetal sheep. J. Physiol. 2007, 578(2):491-506.
74. Bennet L., Dean J.M., Wassink G., Gunn A.J. Differential effects of hypothermia on early and late epileptiform events after severe hypoxia in preterm fetal sheep. J. Neurophysiol. 2007, 97(1):572-578.
75. Gajda Z., Gyengesi E., Hermesz E., Ali K.S., Szente M. Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo. Epilepsia 2003, 44(12):1596-1600.
76. Gajda Z., Hermesz E., Gyengesi E., Szupera Z., Szente M. The functional significance of gap junction channels in the epileptogenicity and seizure susceptibility of juvenile rats. Epilepsia 2006, 47(6):1009-1022.
77. Gomez-Gonzalo M., Losi G., Chiavegato A., Zonta M., Cammarota M., Brondi M., et al. An excitatory loop with astrocytes contributes to drive neurons to seizure threshold. PLoS Biol. 2010, 8(4):e1000352.
78. Evans D.J., Levene M.I., Tsakmakis M. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst. Rev. 2007, 3:CD001240.
79. Kim J.E., Kang T.C. The P2X7 receptor-Pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice. J. Clin. Invest. 2011, 121(5):2037-2047.
80. Mylvaganam S., Zhang L., Wu C., Zhang Z.J., Samoilova M., Eubanks J., et al. Hippocampal seizures alter the expression of the Pannexin and Connexin transcriptome. J. Neurochem. 2010, 112(1):92-102.
81. Northington F.J., Zelaya M.E., O'Riordan D.P., Blomgren K., Flock D.L., Hagberg H., et al. Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as continuum phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain. Neuroscience 2007, 149(4):822-833.
82. Northington F.J., Chavez-Valdez R., Martin L.J. Neuronal cell death in neonatal hypoxia-ischemia. Ann. Neurol. 2011, 69(5):743-758.
83. Wang X., Carlsson Y., Basso E., Zhu C., Rousset C.I., Rasola A., et al. Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J. Neurosci. 2009, 29(8):2588-2596.
84. Cotrina M.L., Lin J.H., Alves-Rodrigues A., Liu S., Li J., Azmi-Ghadimi H., et al. Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(26):15735-15740.
85. Baroja-Mazo A., Barbera-Cremades M., Pelegrin P. The participation of plasma membrane hemichannels to purinergic signaling. Biochim. Biophys. Acta 2013, 1828(1):79-93.
86. Peng W., Cotrina M.L., Han X., Yu H., Bekar L., Blum L., et al. Systemic administration of an antagonist of the ATP-sensitive receptor P2X7 improves recovery after spinal cord injury. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(30):12489-12493.
87. Cotrina M.L., Kang J., Lin J.H., Bueno E., Hansen T.W., He L., et al. Astrocytic gap junctions remain open during ischemic conditions. J. Neurosci. 1998, 18(7):2520-2537.
88. Locovei S., Scemes E., Qiu F., Spray D.C., Dahl G. Pannexin 1 is part of the pore forming unit of the P2X7 receptor death complex. FEBS Lett. 2007, 581(3):483-488.
89. Poornima V., Madhupriya M., Kootar S., Sujatha G., Kumar A., Bera A.K. P2X7 receptor-Pannexin 1 hemichannel association: effect of extracellular calcium on membrane permeabilization. J. Mol. Neurosci. 2012, 46(3):585-594.
90. Smith S.J. Neural signalling neuromodulatory astrocytes. Curr. Biol. 1994, 4(9):807-810.
91. Rothstein J.D., Martin L., Levey A.I., Dykes-Hoberg M., Jin L., Wu D., et al. Localization of neuronal and glial glutamate transporters. Neuron 1994, 13(3):713-725.
92. Ye Z.C., Wyeth M.S., Baltan-Tekkok S., Ransom B.R. Functional hemichannels in astrocytes: a novel mechanism of glutamate release. J. Neurosci. 2003, 23(9):3588-3596.
93. Wallraff A., Kohling R., Heinemann U., Theis M., Willecke K., Steinhauser C. The impact of astrocytic gap junctional coupling on potassium buffering in the hippocampus. J. Neurosci. 2006, 26(20):5438-5447.
94. Walz W. Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int. 2000, 36(4-5):291-300.
95. Rose C.R., Ransom B.R. Gap junctions equalize intracellular Na+ concentration in astrocytes. Glia 1997, 20(4):299-307.
96. Vyskocil F., Kritz N., Bures J. Potassium-selective microelectrodes used for measuring the extracellular brain potassium during spreading depression and anoxic depolarization in rats. Brain Res. 1972, 39(1):255-259.
97. Takahashi S., Shibata M., Fukuuchi Y. Role of sodium ion influx in depolarization-induced neuronal cell death by high KCI or veratridine. Eur. J. Pharmacol. 1999, 372(3):297-304.
98. Tsacopoulos M., Magistretti P.J. Metabolic coupling between glia and neurons. J. Neurosci. 1996, 16(3):877-885.
99. Levitsky L.L., Fisher D.E., Paton J.B., Delannoy C.W. Fasting plasma levels of glucose, acetoacetate, d-β-hydroxybutyrate, glycerol, and lactate in the baboon infant: correlation with cerebral uptake of substrates and oxygen. Pediatr. Res. 1977, 11(4):298-302.
100. Rouach N., Koulakoff A., Abudara V., Willecke K., Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science 2008, 322(5907):1551-1555.
101. Araque A., Sanzgiri R.P., Parpura V., Haydon P.G. Astrocyte-induced modulation of synaptic transmission. Can. J. Physiol. Pharmacol. 1999, 77(9):699-706.
102. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., et al. Control of synaptic strength by glial TNFalpha. Science 2002, 295(5563):2282-2285.
103. Perea G., Araque A. Astrocytes potentiate transmitter release at single hippocampal synapses. Science 2007, 317(5841):1083-1086.
104. Parpura V., Basarsky T.A., Liu F., Jeftinija K., Jeftinija S., Haydon P.G. Glutamate-mediated astrocyte-neuron signalling. Nature 1994, 369(6483):744-747.
105. Mothet J.P., Parent A.T., Wolosker H., Brady R.O., Linden D.J., Ferris C.D., et al. d-serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(9):4926-4931.
106. Stellwagen D., Malenka R.C. Synaptic scaling mediated by glial TNF-alpha. Nature 2006, 440(7087):1054-1059.
107. Gordon G.R., Baimoukhametova D.V., Hewitt S.A., Rajapaksha W.R., Fisher T.E., Bains J.S. Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy. Nat. Neurosci. 2005, 8(8):1078-1086.
108. Pascual O., Casper K.B., Kubera C., Zhang J., Revilla-Sanchez R., Sul J.Y., et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 2005, 310(5745):113-116.
109. Schafer D.P., Lehrman E.K., Stevens B. The quad-partite synapse: microglia-synapse interactions in the developing and mature CNS. Glia 2013, 61(1):24-36.
110. Seth P., Koul N. Astrocyte the star avatar: redefined. J. Biosci. 2008, 33(3):405-421.
111. Guan J., Bennet L., Gluckman P.D., Gunn A.J. Insulin-like growth factor-1 and post-ischemic brain injury. Prog. Neurobiol. 2003, 70(6):443-462.
112. Farkas E., Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 2001, 64(6):575-611.
113. Guan J., Mathai S., Liang H.P., Gunn A.J. Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for treating neurological conditions. Recent Pat. CNS Drug Discov. 2013, 8(2):142-160.
114. McLeod D.S., Grebe R., Bhutto I., Merges C., Baba T., Lutty G.A. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest. Ophthalmol. Visual Sci. 2009, 50(10):4982-4991.
115. Biesemeier A., Taubitz T., Julien S., Yoeruek E., Schraermeyer U. Choriocapillaris breakdown precedes retinal degeneration in age-related macular degeneration. Neurobiol. Aging 2014, 35(11):2562-2573.
116. Tam J., Dhamdhere K.P., Tiruveedhula P., Manzanera S., Barez S., Bearse M.A., et al. Disruption of the retinal parafoveal capillary network in type 2 diabetes before the onset of diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 2011, 52(12):9257-9266.
117. McIntyre T.M., Prescott S.M., Weyrich A.S., Zimmerman G.A. Cell-cell interactions: leukocyte-endothelial interactions. Curr. Opin. Hematol. 2003, 10(2):150-158.
118. Oviedo-Orta E., Howard Evans W. Gap junctions and Connexin-mediated communication in the immune system. Biochim. Biophys. Acta 2004, 1662(1-2):102-112.
119. Eugenin E.A., Branes M.C., Berman J.W., Saez J.C. TNF-alpha plus IFN-gamma induce Connexin 43 expression and formation of gap junctions between human monocytes/macrophages that enhance physiological responses. J. Immunol. 2003, 170(3):1320-1328.
120. Sarieddine M.Z., Scheckenbach K.E., Foglia B., Maass K., Garcia I., Kwak B.R., et al. Connexin 43 modulates neutrophil recruitment to the lung. J. Cell. Mol. Med. 2009, 13(11-12):4560-4570.
121. Coutinho P., Qiu C., Frank S., Wang C.M., Brown T., Green C.R., et al. Limiting burn extension by transient inhibition of Connexin 43 expression at the site of injury. Br. J. Plast Surg. 2005, 58(5):658-667.
122. Qiu C., Coutinho P., Frank S., Franke S., Law L.Y., Martin P., et al. Targeting Connexin 43 expression accelerates the rate of wound repair. Curr. Biol. 2003, 13(19):1697-1703.
123. de Bock M., Culot M., Wang N., Bol M., Decrock E., De Vuyst E., et al. Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 2011, 31(9):1942-1957.
124. Nagasawa K., Chiba H., Fujita H., Kojima T., Saito T., Endo T., et al. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J. Cell. Physiol. 2006, 208(1):123-132.
125. Krueger M., Hartig W., Reichenbach A., Bechmann I., Michalski D. Blood-brain barrier breakdown after embolic stroke in rats occurs without ultrastructural evidence for disrupting tight junctions. PLoS One 2013, 8(2):e56419.
126. Zhang J., O'Carroll S.J., Danesh-Meyer H.V., Van der Heyde H.C., Becker D.L., Nicholson L.F.B., et al. Connexin-based therapeutic approaches to inflammation in the central nervous system. Connexin Cell Communication Channels: Roles in the Immune System and Immunopathology 2013, 273-305. Taylor and Francis Group, CRC Press, Boca Raton, Florida. E. Oviedo-Orta, B.R. Kwak, W.H. Evans (Eds.).
127. Ormonde S., Chou C.Y., Goold L., Petsoglou C., Al-Taie R., Sherwin T., et al. Regulation of Connexin 43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds. J. Membr. Biol. 2012, 245(7):381-388.
128. Rhett J.M., Jourdan J., Gourdie R.G. Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1. Mol. Biol. Cell. 2011, 22(9):1516-1528.
129. Hunter A.W., Barker R.J., Zhu C., Gourdie R.G. Zonula occludens-1 alters Connexin 43 gap junction size and organization by influencing channel accretion. Mol. Biol. Cell. 2005, 16(12):5686-5698.
130. Ghatnekar G.S., Grek C.L., Armstrong D.G., Desai S.C., Gourdie R.G. The effect of a Connexin 43-based peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial. J. Invest. Dermatol. 2015, 135(1):289-298.
131. Wang N., De Bock M., Decrock E., Bol M., Gadicherla A., Bultynck G., et al. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening. Neuropharmacology 2013, 75:506-516.
132. Abudara V., Bechberger J., Freitas-Andrade M., De Bock M., Wang N., Bultynck G., et al. The Connexin 43 mimetic peptide Gap 19 inhibits hemichannels without altering gap junctional communication in astrocytes. Front Cell. Neurosci. 2014, 8:306.